Stifel Financial
MBOT icon

Stifel Financial’s Microbot Medical MBOT Stock Holding History

Stifel Financial’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
589,924
+16,849
+3% +$34.3K ﹤0.01% 2463
2026
Q1 		$1.38M Buy
573,075
+307,085
+115% +$686K ﹤0.01% 2217
2025
Q4 		$532K Buy
265,990
+108,498
+69% +$257K ﹤0.01% 2825
2025
Q3 		$480K Buy
157,492
+141,388
+878% +$441K ﹤0.01% 2837
2025
Q2 		$40.6K Buy
16,104
+5,445
+51% +$13K ﹤0.01% 3425
2025
Q1 		$16.1K Buy
10,659
+339
+3% +$599 ﹤0.01% 3402
2024
Q4 		$11.6K Sell
10,320
-1
-0% -$1 ﹤0.01% 3364
2024
Q3 		$9.23K Hold
10,321
– – ﹤0.01% 3355
2024
Q2 		$10.5K Hold
10,321
– – ﹤0.01% 3347
2024
Q1 		$12.7K Hold
10,321
– – ﹤0.01% 3323
2023
Q4 		$16.9K Buy
+10,321
New +$13.7K ﹤0.01% 3279

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Stifel Financial's MBOT Position: Q2 2026 in Review

Stifel Financial increased its Microbot Medical (MBOT) stake by 2.9% in Q2 2026, buying an estimated $34.3K and bringing the position to 589,924 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2463.

Stifel Financial first reported a position in MBOT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.38M in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Stifel Financial held 589,924 shares of Microbot Medical worth $1.15M as of Q2 2026.
  • Stifel Financial bought 16,849 Microbot Medical shares in Q2 2026, an estimated $34.3K.
  • Microbot Medical made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2463 holding.
  • Stifel Financial first reported a position in Microbot Medical in Q4 2023 and has held it in 11 quarters since.
  • Stifel Financial's Microbot Medical position peaked at $1.38M in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.